Related Experiment Videos

A new class of antiemetic agents on the horizon

Cynthia N Rittenberg¹

¹cindyrit@bellsouth.net

Clinical Journal of Oncology Nursing

|March 14, 2002

Abstract:

This article reviews a new class of antiemetic agents, the neurokinin-1 (NK-1) receptor antagonists (RAs). Clinical trials of an NK-1 RA, aprepitant, are ongoing.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2017

2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2016

Left behind: cancer disparities in the developed world.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2016

Assessment and measurement of medication adherence: oral agents for cancer.

Clinical journal of oncology nursing·2015

Analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting with moderately and highly emetogenic chemotherapy.

Future oncology (London, England)·2013

An oral history of MASCC, its origin and development from MASCC's beginnings to 2009.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2010

See all related articles